Display options
Cite
Yamaguchi T, Seki T, Miyasaka C, et al. Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report. Oncol Lett. 2015;9(4):1633-1636doi: 10.3892/ol.2015.2934.
Yamaguchi, T., Seki, T., Miyasaka, C., Inokuchi, R., Kawamura, R., Sakaguchi, Y., Murata, M., Matsuzaki, K., Nakano, Y., Uemura, Y., & Okazaki, K. (2015). Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report. Oncology letters, 9(4), 1633-1636. https://doi.org/10.3892/ol.2015.2934
Yamaguchi, Takashi, et al. "Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report." Oncology letters vol. 9,4 (2015): 1633-1636. doi: https://doi.org/10.3892/ol.2015.2934
Yamaguchi T, Seki T, Miyasaka C, Inokuchi R, Kawamura R, Sakaguchi Y, Murata M, Matsuzaki K, Nakano Y, Uemura Y, Okazaki K. Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report. Oncol Lett. 2015 Apr;9(4):1633-1636. doi: 10.3892/ol.2015.2934. Epub 2015 Feb 05. PMID: 25789013; PMCID: PMC4356407.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2015 Apr;9(4):1633-1636. doi: 10.3892/ol.2015.2934. Epub 2015 Feb 05.

Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report.

Oncology letters

Takashi Yamaguchi, Toshihito Seki, Chika Miyasaka, Ryosuke Inokuchi, Rinako Kawamura, Yuutaku Sakaguchi, Miki Murata, Koichi Matsuzaki, Yorika Nakano, Yoshiko Uemura, Kazuichi Okazaki

Affiliations

  1. Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka 570-8507, Japan ; Liver Disease Center, Kansai Medical University Takii Hospital, Osaka 570-8507, Japan.
  2. Department of Diagnostic Pathology, Kansai Medical University, Osaka 570-8507, Japan.
  3. Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka 570-8507, Japan.

PMID: 25789013 PMCID: PMC4356407 DOI: 10.3892/ol.2015.2934

Abstract

Sorafenib is a multikinase inhibitor currently approved in Japan for the treatment of unresectable hepatocellular carcinoma. Interstitial pneumonia induced by sorafenib may have a fatal outcome, and therefore, has recently been the focus of many studies. The current report presents an autopsy case of diffuse alveolar damage (DAD) that occurred in a 59-year-old male, who had been treated with sorafenib. The patient had been given sorafenib for six months and had exhibited no respiratory symptoms during this time. However, 19 days after sorafenib treatment was resumed, acute interstitial pneumonia developed. In previously reported cases, the first symptoms of pulmonary toxicity appeared following a limited treatment duration with sorafenib; this was in contrast to the patient in the current study, who developed the first symptoms after eight months. We therefore conclude that physicians must be aware of interstitial pneumonia as a potential pulmonary toxicity associated with sorafenib treatment when treatment with sorafenib is resumed, even after prolonged use. In addition, to best of our knowledge, this is the first case of a postmortem examination reported in patient with interstitial pneumonia induced by sorafenib treatment.

Keywords: diffuse alveolar damage; drug-induced interstitial pneumonia; hepatocellular carcinoma; molecular-targeted agent; sorafenib

References

  1. Cancer. 1954 May;7(3):462-503 - PubMed
  2. Cancer Res. 2004 Oct 1;64(19):7099-109 - PubMed
  3. Ann Intern Med. 2004 Sep 21;141(6):440-5 - PubMed
  4. Lung Cancer. 2010 Feb;67(2):248-50 - PubMed
  5. Clin J Gastroenterol. 2012;5(4):407-12 - PubMed
  6. Scand J Immunol. 2009 Mar;69(3):268-74 - PubMed
  7. Target Oncol. 2011 Dec;6(4):235-43 - PubMed
  8. Crit Care Med. 2007 Sep;35(9):2164-70 - PubMed
  9. Histopathology. 2009 Jan;54(1):90-103 - PubMed
  10. Chest. 2008 May;133(5):1120-7 - PubMed
  11. Lancet. 2003 Dec 6;362(9399):1907-17 - PubMed
  12. Eur Respir J. 2005 Jan;25(1):139-46 - PubMed
  13. Open Respir Med J. 2012;6:63-74 - PubMed
  14. Gut Liver. 2010 Dec;4(4):543-6 - PubMed
  15. Br J Cancer. 2004 Aug;91 Suppl 2:S24-30 - PubMed

Publication Types